Affinage

CBLN3

Cerebellin-3 · UniProt Q6UW01

Length
205 aa
Mass
21.5 kDa
Annotated
2026-04-28
20 papers in source corpus 7 papers cited in narrative 7 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

CBLN3 is a secreted C1q-domain glycoprotein expressed selectively in cerebellar granule cells that functions exclusively as a heteromeric partner of CBLN1 to regulate cerebellar synapse integrity (PMID:10964938, PMID:16930405). Unlike other cerebellin family members, CBLN3 cannot form homomers or be secreted independently; a single arginine residue in its N-terminal domain causes ER retention, which is relieved upon CBLN1 binding through a 'hide-and-run' mechanism, making CBLN1 obligatory for CBLN3 trafficking and secretion (PMID:17030622, PMID:17331201). In the absence of CBLN3, CBLN1 levels increase approximately sixfold in the cerebellum due to escape from endolysosomal degradation, indicating that CBLN3 quantitatively regulates CBLN1 availability (PMID:17030622, PMID:18001291). The CBLN1–CBLN3 heteromeric complex accumulates in the synaptic cleft of parallel fiber–Purkinje cell synapses where it colocalizes with GluRδ2, positioning it as a trans-synaptic signaling component in cerebellar circuit development and plasticity (PMID:19250438).

Mechanistic history

Synthesis pass · year-by-year structured walk · 7 steps
  1. 2000 High

    Identification of CBLN3 as a CBLN1-binding partner established the existence of a heteromeric cerebellin complex, resolving the question of whether cerebellin family members interact directly.

    Evidence Yeast two-hybrid screen with specificity controls and in vitro binding assays

    PMID:10964938

    Open questions at the time
    • Whether CBLN3 is secreted or has independent function outside the CBLN1 complex was unknown
    • No in vivo localization or functional evidence
  2. 2006 High

    Demonstration that CBLN3 is ER-retained unless bound to CBLN1 — via a steric clash from a single arginine — defined a 'hide-and-run' secretion mechanism and showed that CBLN3 loss elevates CBLN1 levels sixfold, revealing a reciprocal regulatory relationship.

    Evidence cbln1-null and cbln3-null mouse phenotyping, site-directed mutagenesis, structural modeling, and secretion assays in heterologous cells

    PMID:17030622

    Open questions at the time
    • The stoichiometry of the CBLN1–CBLN3 complex was not resolved
    • Whether the sixfold CBLN1 increase in cbln3-null mice has functional consequences at the synapse was untested
  3. 2006 Medium

    Mapping Cbln3 mRNA expression exclusively to postnatal cerebellar granule cells defined its spatiotemporal expression domain, separating it from other family members.

    Evidence RT-PCR, Northern blot, and in situ hybridization across developmental stages

    PMID:16930405

    Open questions at the time
    • Protein-level expression was not directly assessed
    • No functional manipulation to test whether the late postnatal onset is functionally significant
  4. 2007 High

    Independent replication confirmed CBLN3 ER/cis-Golgi retention and CBLN1-dependent secretion, and showed that CBLN3 is nearly completely degraded in cbln1-null granule cells, solidifying the obligate dependence model.

    Evidence Co-expression in heterologous cells, immunofluorescence, and cbln1-null granule cell analysis

    PMID:17331201

    Open questions at the time
    • The degradation pathway for CBLN3 in the absence of CBLN1 was not defined
    • Whether CBLN3 modifies CBLN1 signaling properties or merely alters its levels was unresolved
  5. 2007 Medium

    Showing that CBLN3 loss increases CBLN1 specifically in cerebellum via diversion from endolysosomal degradation revealed a cell-type-specific regulatory mechanism controlling CBLN1 abundance.

    Evidence Immunohistochemistry in cbln3-null mice with lysosomal marker colocalization

    PMID:18001291

    Open questions at the time
    • Direct biochemical demonstration of CBLN1 endolysosomal routing by CBLN3 was not provided
    • Whether the increased CBLN1 in cbln3-null cerebellum alters synaptic function was not tested
  6. 2009 Medium

    Ultrastructural co-localization of CBLN1, CBLN3, and GluRδ2 at parallel fiber–Purkinje cell synaptic clefts placed the heteromeric complex at its site of action, linking it to trans-synaptic signaling.

    Evidence Pre-embedding immunohistochemistry with pepsin antigen retrieval and postembedding immunogold electron microscopy

    PMID:19250438

    Open questions at the time
    • No direct functional evidence that CBLN3 modulates GluRδ2 signaling at the synapse
    • Whether CBLN3 contacts GluRδ2 directly or only through CBLN1 was unknown
  7. 2017 Medium

    Reporter knockin mice confirmed that CBLN3 uniquely among the family requires CBLN1 for assembly into secreted hexameric complexes, reinforcing its obligate heteromeric nature.

    Evidence Knockin reporter mice and heterologous cell expression studies

    PMID:28714144

    Open questions at the time
    • Exact stoichiometry (e.g., trimer-of-dimers composition) of CBLN1–CBLN3 heterohexamers was not determined
    • Functional distinction between CBLN1 homohexamers and CBLN1–CBLN3 heterohexamers at the synapse remains unknown

Open questions

Synthesis pass · forward-looking unresolved questions
  • It remains unknown whether CBLN3 incorporation into CBLN1 complexes changes the binding affinity or signaling output at GluRδ2-containing synapses, and whether CBLN3 loss produces distinct behavioral or synaptic phenotypes beyond those explained by altered CBLN1 levels.
  • No structure of the CBLN1–CBLN3 heteromeric complex
  • No direct electrophysiological or behavioral analysis specifically attributable to CBLN3 function
  • Whether CBLN3 interacts with neurexins or other synaptic organizers independent of CBLN1 is untested

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0005198 structural molecule activity 3
Localization
GO:0005576 extracellular region 3 GO:0005783 endoplasmic reticulum 2
Pathway
R-HSA-9609507 Protein localization 3 R-HSA-112316 Neuronal System 2
Partners
Complex memberships
CBLN1-CBLN3 heterohexamer

Evidence

Reading pass · 7 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2000 CBLN3 was identified as a novel Cbln1-binding protein via yeast two-hybrid screen. CBLN3 binds avidly to CBLN1 to form heteromeric complexes, while CBLN3 homomeric association is weak. This interaction is specific, as C1qB binds to neither CBLN1 nor CBLN3. CBLN3 contains a C1q signature domain and signal sequence for secretion. Yeast two-hybrid screen, in vitro binding assays The Journal of neuroscience High 10964938
2006 CBLN3 cannot form homomeric complexes and is retained in the endoplasmic reticulum unless bound to CBLN1. A single arginine residue in CBLN3 creates a steric clash that causes ER retention, which is masked upon CBLN1 binding — a 'hide-and-run' mechanism. CBLN1 is essential for CBLN3 secretion; in cbln1-null mice, CBLN3 is absent (degraded), while in cbln3-null mice, CBLN1 levels increase ~sixfold. Double-null mice phenocopy cbln1 single knockouts. cbln1-null and cbln3-null mouse analysis, mutation analysis, structural modeling, secretion assays Molecular and cellular biology High 17030622
2007 CBLN3 is not secreted when expressed alone but is retained in the endoplasmic reticulum or cis-Golgi due to its N-terminal domain. When co-expressed with CBLN1 in heterologous cells, a proportion of CBLN3 is secreted together with CBLN1. In cbln1-null granule cells, CBLN3 is almost completely degraded, confirming CBLN1 dependence for CBLN3 trafficking. Heterologous cell expression, co-expression experiments, analysis of cbln1-null granule cells, immunofluorescence The European journal of neuroscience High 17331201
2006 Cbln3 mRNA expression is selective to cerebellar granule cells throughout development, with onset as late as postnatal day 7-10, distinguishing it from other Cbln family members. RT-PCR, Northern blot, in situ hybridization The European journal of neuroscience Medium 16930405
2009 CBLN1 and CBLN3 co-accumulate at parallel fiber-Purkinje cell synaptic clefts, where they colocalize with GluRdelta2, providing anatomical evidence that all three molecules operate together in a common signaling pathway regulating cerebellar circuit development and synaptic plasticity. Light and electron microscopic immunohistochemistry with pepsin pretreatment and postembedding immunogold The European journal of neuroscience Medium 19250438
2007 In cbln3-null mice, Cbln1 immunoreactivity in the cerebellum increases dramatically, but is unchanged in extracerebellar neurons, indicating CBLN3 regulates CBLN1 levels via the endolysosomal degradation pathway specifically in cerebellar granule cells. Cbln1 localizes to the endolysosomal compartment of neurons. Immunohistochemistry of cbln3-null mice, colocalization with cathepsin D (lysosomal marker), cbln1-lacZ transgenic mice The European journal of neuroscience Medium 18001291
2017 Unlike CBLN1, CBLN2, and CBLN4 which autonomously assemble into homohexamers, CBLN3 requires CBLN1 for assembly and secretion, forming heteromeric complexes. This was confirmed in reporter knockin mice and cell expression studies. Knockin reporter mice, expression studies in heterologous cells The Journal of comparative neurology Medium 28714144

Source papers

Stage 0 corpus · 20 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2006 Distinct expression of Cbln family mRNAs in developing and adult mouse brains. The European journal of neuroscience 92 16930405
2000 Cbln3, a novel member of the precerebellin family that binds specifically to Cbln1. The Journal of neuroscience : the official journal of the Society for Neuroscience 68 10964938
2017 Cerebellins are differentially expressed in selective subsets of neurons throughout the brain. The Journal of comparative neurology 53 28714144
2006 Cbln1 is essential for interaction-dependent secretion of Cbln3. Molecular and cellular biology 49 17030622
2007 Characterization of a transneuronal cytokine family Cbln--regulation of secretion by heteromeric assembly. The European journal of neuroscience 47 17331201
2009 Cbln1 accumulates and colocalizes with Cbln3 and GluRdelta2 at parallel fiber-Purkinje cell synapses in the mouse cerebellum. The European journal of neuroscience 31 19250438
2007 Mapping of Cbln1-like immunoreactivity in adult and developing mouse brain and its localization to the endolysosomal compartment of neurons. The European journal of neuroscience 31 18001291
2008 Expression of precerebellins in cultured rat calvaria osteoblast-like cells. International journal of molecular medicine 16 18813864
2009 Precerebellin-related genes and precerebellin 1 peptide in endocrine glands of the rat - pattern of their expression. International journal of molecular medicine 14 19082514
2009 Insulinostatic activity of cerebellin--evidence from in vivo and in vitro studies in rats. Regulatory peptides 12 19481574
2020 GNG13 Is a Potential Marker of the State of Health of Alzheimer's Disease Patients' Cerebellum. Journal of molecular neuroscience : MN 10 33057964
2010 Identification of cerebellin2 in chick and its preferential expression by subsets of developing sensory neurons and their targets in the dorsal horn. The Journal of comparative neurology 9 20506477
2019 Mouse models and strain-dependency of Chédiak-Higashi syndrome-associated neurologic dysfunction. Scientific reports 8 31043676
2020 Comparative transcriptome analysis of normal and CD44-deleted mouse brain under chronic infection with Toxoplasma gondii. Acta tropica 5 32544399
2024 Biomarker discovery in progressive supranuclear palsy from human cerebrospinal fluid. Clinical proteomics 4 39342078
2021 The porcine cerebellin gene family. Gene 3 34274480
2026 Association of prenatal glycemic marker cumulative exposure with placental DNA methylation change. The Journal of clinical endocrinology and metabolism 1 41507059
2026 Biomarker for craving and acamprosate treatment response in patients with alcohol use disorder: insights from multi-omics. Molecular psychiatry 0 41741704
2026 Structural Architecture and Evolutionary Conservation of Cerebellin-Mediated Trans-Synaptic Signaling. Synapse (New York, N.Y.) 0 41995212
2025 Integrative multi-omics analysis of druggable genes for therapeutic target identification in polycystic ovary syndrome. Journal of ovarian research 0 41388545